F. Gamza
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Oncology 2
- Lung Cancer Research Studies 1
- Co-authors
- Frank V. Fossella (2 shared papers)Luz Hammershaimb (2 shared papers)Frank Dunphy (1 shared paper)Leonard Kalman (1 shared paper)Daniel D. Karp (1 shared paper)Russell F. DeVore (1 shared paper)Vincent A. Miller (1 shared paper)Mark G. Kris (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Lung Cancer (1 paper)European Journal of Cancer Supplements (2 papers)
- Partner nations
- United StatesBelgiumAustralia
In The Last Decade
F. Gamza
5 papers receiving 1.1k citations
F. Gamza's Hit Papers
Peers
Comparison fields: 5 of 47
- Pulmonary and Respiratory Medicine 779
- Oncology 574
- Cancer Research 57
- Otorhinolaryngology 14
- Molecular Biology 143
Countries citing papers authored by F. Gamza
This map shows the geographic impact of F. Gamza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Gamza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Gamza more than expected).
Fields of papers citing papers by F. Gamza
This network shows the impact of papers produced by F. Gamza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Gamza. The network helps show where F. Gamza may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Gamza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Hit paper breakdown → | 2000 | 1123 |
| 2 | 2000 | 43 | |
| 3 | 2008 | 8 | |
| 4 | 2008 | 4 | |
| 5 | 2008 | 3 |
About F. Gamza
F. Gamza is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 5 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Pharmacogenetics and Drug Metabolism (1 paper), Lung Cancer Research Studies (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Cancer therapeutics and mechanisms (1 paper), Plant-based Medicinal Research (1 paper), Chromatography in Natural Products (1 paper) and Pharmaceutical studies and practices (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (779 citations), Oncology (574 citations), Cancer Research (57 citations), Otorhinolaryngology (14 citations) and Molecular Biology (143 citations). F. Gamza has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include Frank V. Fossella, Luz Hammershaimb, Frank Dunphy, Leonard Kalman, Daniel D. Karp, Russell F. DeVore, Vincent A. Miller, Mark G. Kris, Jeffrey Crawford and Jin Soo Lee. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.